Incretin-based drugs as potential therapy for neurodegenerative diseases: current status and perspectives
Year: 2022
Type: review
Source: Pharmacology & Therapeutics
Authors: Federica Ferrari, Antonio Moretti, Roberto Federico Villa
Institution: University of Pavia
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: incretin-based therapy, Alzheimer's disease, Parkinson's disease, neurodegenerative diseases, GLP-1 receptor agonists, DPP-4 inhibitors, GIP/GLP-1 receptor agonist, insulin resistance, type 2 diabetes risk factors, blood-brain barrier penetration, neuroprotection, amyloid plaques, tau hyperphosphorylation, dopaminergic neuron loss, neuroinflammation, mitochondrial protection, clinical trials, adverse effects, learning and memory, motor function
Open Access status: closed
OpenAlex ID: W4294550772
